Nimbex Preservative Free is a drug owned by Abbvie Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 26, 2012. Details of Nimbex Preservative Free's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5453510 | Neuromuscular blocking agents |
Sep, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Nimbex Preservative Free is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Nimbex Preservative Free's family patents as well as insights into ongoing legal events on those patents.
Nimbex Preservative Free's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Nimbex Preservative Free's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 26, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Nimbex Preservative Free Generic API suppliers:
Cisatracurium Besylate is the generic name for the brand Nimbex Preservative Free. 16 different companies have already filed for the generic of Nimbex Preservative Free, with Piramal Critical having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Nimbex Preservative Free's generic
How can I launch a generic of Nimbex Preservative Free before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Nimbex Preservative Free's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Nimbex Preservative Free's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Nimbex Preservative Free -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 2 mg/mL, 10 mL vial | 12 Aug, 2009 | 1 | 03 Feb, 2012 | 26 Sep, 2012 | Eligible |
| 2 mg/mL, 5 mL vial and 10 mg/mL, 20 mL vial | 04 Aug, 2009 | 1 | 03 Feb, 2012 | 26 Sep, 2012 | Eligible |
Alternative Brands for Nimbex Preservative Free
Nimbex Preservative Free which is used for inducing muscle relaxation during surgical procedures., has several other brand drugs in the same treatment category and using the same active ingredient (Cisatracurium Besylate). Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||
|---|---|---|---|---|
| Abbvie |
| |||
Apart from brand drugs containing the same ingredient, some generics have also been filed for Cisatracurium Besylate, Nimbex Preservative Free's active ingredient. Check the complete list of approved generic manufacturers for Nimbex Preservative Free
About Nimbex Preservative Free
Nimbex Preservative Free is a drug owned by Abbvie Inc. It is used for inducing muscle relaxation during surgical procedures. Nimbex Preservative Free uses Cisatracurium Besylate as an active ingredient. Nimbex Preservative Free was launched by Abbvie in 1995.
Approval Date:
Nimbex Preservative Free was approved by FDA for market use on 15 December, 1995.
Active Ingredient:
Nimbex Preservative Free uses Cisatracurium Besylate as the active ingredient. Check out other Drugs and Companies using Cisatracurium Besylate ingredient
Treatment:
Nimbex Preservative Free is used for inducing muscle relaxation during surgical procedures.
Dosage:
Nimbex Preservative Free is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 2MG BASE/ML | INJECTABLE | Discontinued | INJECTION |
| EQ 10MG BASE/ML | INJECTABLE | Discontinued | INJECTION |